Literature DB >> 20388629

Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.

R Brian Doctor1, Natalie J Serkova, Kendra M Hasebroock, Iram Zafar, Charles L Edelstein.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disease that results in the development of cystic kidneys and liver. Pkd2(WS25/-) mice are a key genetic mouse model of human ADPKD that recapitulate the 'molecular recessive' nature of human ADPKD. Providing the foundation for future long-term studies, the present work documents distinct patterns of long-term cyst growth in the kidneys and liver of male and female pkd2(WS25/-) mice.
METHODS: Gravimetric measurements documented the progression of kidney and liver growth in male and female pkd2(WS25/-) mice over 12 months. A fast imaging with steady-state precision-magnetic resonance imaging (FISP-MRI) technique to measure kidney and liver organ and cyst volumes was optimized and validated. Longitudinal FISP-MRI analyses of changes in cyst volumes were performed in pkd2(WS25/-) mice over 15 months.
RESULTS: Male and female pkd2(WS25/-) mice had significant increases in kidney weights after 4 months of age. The progression of kidney growth was minimal after 4 months of age. Liver cyst growth in male pkd2(WS25/-) mice was minimal after 4 months of age but showed an accelerated rate of growth after 8 months of age. Female pkd2(WS25/-) mice also showed accelerated growth but this was delayed in time when compared with male pkd2(WS25/-) mice.
CONCLUSIONS: Pkd2(WS25/-) mice are a genetic mouse model that recapitulates the early phenotypic characteristics of human ADPKD kidney cystogenesis. Male pkd2(WS25/-) mice consistently display a late progression in liver growth that is seen in clinically impacted livers of human ADPKD patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388629      PMCID: PMC2980992          DOI: 10.1093/ndt/gfq195

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  27 in total

1.  Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.

Authors:  Young Rae Lee; Kyu-Beck Lee
Journal:  Nephron Clin Pract       Date:  2006-04-24

2.  Images in clinical medicine. Liver transplantation for polycystic liver disease.

Authors:  William J Wall
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

3.  In vivo proton magnetic resonance imaging and localized spectroscopic analysis of polycystic kidney disease in DBA/2FG-pyc mice.

Authors:  R A Towner; T Yamaguchi; D J Philbrick; B J Holub; E G Janzen; H Takahashi
Journal:  Magn Reson Imaging       Date:  1991       Impact factor: 2.546

4.  Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.

Authors:  Claudia Weidensteiner; Martin Rausch; Paul M J McSheehy; Peter R Allegrini
Journal:  J Magn Reson Imaging       Date:  2006-09       Impact factor: 4.813

5.  Somatic inactivation of Pkd2 results in polycystic kidney disease.

Authors:  G Wu; V D'Agati; Y Cai; G Markowitz; J H Park; D M Reynolds; Y Maeda; T C Le; H Hou; R Kucherlapati; W Edelmann; S Somlo
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

6.  Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts.

Authors:  G T Everson; A Scherzinger; N Berger-Leff; J Reichen; D Lezotte; M Manco-Johnson; P Gabow
Journal:  Hepatology       Date:  1988 Nov-Dec       Impact factor: 17.425

7.  Volume progression in polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Phillip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; John P Miller
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

8.  Micro-MRI methods to detect renal cysts in mice.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Martin W Brechbiel; Sang-Kyung Jo; Xuzhen Hu; Tianxin Yang; Bhalchandra A Diwan; Thomas A Waldmann; Jurgen Schnermann; Peter L Choyke; Robert A Star
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

9.  Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.

Authors:  R Sherstha; C McKinley; P Russ; A Scherzinger; T Bronner; R Showalter; G T Everson
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

10.  Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Authors:  Kyongtae T Bae; Fang Zhu; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Lisa M Guay-Woodford; Deborah A Baumgarten; Bernard F King; Louis H Wetzel; Philip J Kenney; Marijn E Brummer; William M Bennett; Saulo Klahr; Catherine M Meyers; Xiaoling Zhang; Paul A Thompson; J Philip Miller
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 8.237

View more
  6 in total

1.  Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).

Authors:  Franck Belibi; Iram Zafar; Kameswaran Ravichandran; Anamarija Bauer Segvic; Alkesh Jani; Danica Galesic Ljubanovic; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

Review 2.  Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging.

Authors:  Joshua M Thurman; Natalie J Serkova
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

3.  An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Iram Zafar; Zhibin He; R Brian Doctor; Radu Moldovan; Adam E Mullick; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

4.  Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Abdullah Ozkok; Qian Wang; Adam E Mullick; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

5.  Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance.

Authors:  Elizabeth M Steinert; Jason M Schenkel; Kathryn A Fraser; Lalit K Beura; Luke S Manlove; Botond Z Igyártó; Peter J Southern; David Masopust
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

6.  Automated total kidney volume measurements in pre-clinical magnetic resonance imaging for resourcing imaging data, annotations, and source code.

Authors:  Marie E Edwards; Sigapriya Periyanan; Deema Anaam; Adriana V Gregory; Timothy L Kline
Journal:  Kidney Int       Date:  2020-08-20       Impact factor: 10.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.